These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14240336)

  • 1. [EFFECT OF GRISEOFULVIN ON FUNCTIONAL CONDITIONS OF THE HORNY LAYER OF THE SKIN].
    KONDRASHOV VA
    Vestn Dermatol Venerol; 1964 Aug; 38():25-8. PubMed ID: 14240336
    [No Abstract]   [Full Text] [Related]  

  • 2. [FURTHER CONSIDERATIONS ON THE MECHANISM OF ACTION OF GRISEOFULVIN IN THE THERAPY OF DERMATOPHYTOSIS].
    PINETTI P
    Mycopathol Mycol Appl; 1965 Mar; 25():87-99. PubMed ID: 14331330
    [No Abstract]   [Full Text] [Related]  

  • 3. TREATMENT OF CUTANEOUS FUNGOUS INFECTION WITH TOLNAFTATE.
    VANDEERVE J
    J S C Med Assoc; 1964 Nov; 60():351-3. PubMed ID: 14210891
    [No Abstract]   [Full Text] [Related]  

  • 4. [INTERRUPTED METHOD OF GRISEOFULVIN THERAPY OF DERMATOMYCOSES].
    RODZIEWICZ H; MITURSKA M; MICHALSKA I
    Pol Tyg Lek; 1964 Jun; 19():912-4. PubMed ID: 14187763
    [No Abstract]   [Full Text] [Related]  

  • 5. [GRISEOFULVIN IN THE TREATMENT OF DERMATOMYCOSES].
    ARIEVICH AM; VIKHREVA OG; TIUFILINA OV; LIVANOVA NK; SHEKLAKOVA AA; VATOLINA VM; BLUDOVA NM
    Antibiotiki; 1964 May; 9():457-61. PubMed ID: 14242811
    [No Abstract]   [Full Text] [Related]  

  • 6. [GRISEOFULVIN IN THE TREATMENT OF DERMATOMYCOSES].
    SHETSIRULI LT; GELASHVILI AP; ROBAKIDZE TI
    Vestn Dermatol Venerol; 1964 Jul; 38():57-60. PubMed ID: 14227839
    [No Abstract]   [Full Text] [Related]  

  • 7. [CLINICO-MORPHOLOGICAL CHANGES IN DERMATOMYCOSIS PATIENTS TREATED WITH GRISEOFULVIN].
    TRIZNA IB
    Antibiotiki; 1964 Nov; 9():1003-7. PubMed ID: 14320470
    [No Abstract]   [Full Text] [Related]  

  • 8. [THERAPY OF DERMATOMYCOSES WITH GRISEOFULVIN M (MICROFINE)].
    LEDIG R
    Z Haut Geschlechtskr; 1964 Mar; 36():149-53. PubMed ID: 14184308
    [No Abstract]   [Full Text] [Related]  

  • 9. TOLNAFTATE, A POTENT TOPICAL ANTIFUNGAL AGENT.
    ROBINSON HM; RASKIN J
    Arch Dermatol; 1965 Apr; 91():372-6. PubMed ID: 14275504
    [No Abstract]   [Full Text] [Related]  

  • 10. [FINDINGS IN THE FOLLOW-UP OF GRISEOFULVIN-TREATED DERMATOMYCOSES AND ONYCHOMYCOSES].
    KRUEGER H; KAUL A
    Z Haut Geschlechtskr; 1964 Nov; 37():362-5. PubMed ID: 14334523
    [No Abstract]   [Full Text] [Related]  

  • 11. GRISEOFULVIN-CONTAINING MEDIUM FOR SIMPLIFIED DIAGNOSIS OF DERMATOPHYTOSIS.
    BLANK H; REBELL G
    Arch Dermatol; 1965 Sep; 92():319-22. PubMed ID: 14329239
    [No Abstract]   [Full Text] [Related]  

  • 12. [VARIOUS STRAINS OF DERMATOPHYTES ISOLATED FROM ROUTINE MATERIALS AND THEIR SENSITIVITY TO GRISEOFULVIN].
    CETIN ET; OKE N; KASIMOGLU O
    Tip Fak Mecm; 1964; 27():27-31. PubMed ID: 14134298
    [No Abstract]   [Full Text] [Related]  

  • 13. GRISEOFULVIN: BIOLOGY AND CLINICAL USEFULNESS. A REVIEW.
    ANDERSON DW
    Ann Allergy; 1965 Feb; 23():103-10. PubMed ID: 14255937
    [No Abstract]   [Full Text] [Related]  

  • 14. WHO WILL BENEFIT FROM GRISEOFULVIN?
    KINGERY FA
    JAMA; 1964 Oct; 190():149. PubMed ID: 14191484
    [No Abstract]   [Full Text] [Related]  

  • 15. Report on the International Conference on Griseofulvin and Dermatomycoses held in Miami, Florida, on October 26 and 27, 1959.
    SULZBERGER MB; GOLDFARB N; ROSENTHAL S
    Excerpta Med; 1959 Dec; [XIII] 13():625-6. PubMed ID: 13854981
    [No Abstract]   [Full Text] [Related]  

  • 16. ERYTHEMA ANNULARE CENTRIFUGUM AS A DERMATOPHYTID.
    ELMOFTY AM; NADA MM
    J Egypt Med Assoc; 1963; 46():979-84. PubMed ID: 14162117
    [No Abstract]   [Full Text] [Related]  

  • 17. [CURRENT DEVELOPMENTS AND ECONOMIC ASPECTS OF THE THERAPY OF MYCOSES].
    BRUNNER N
    Wien Med Wochenschr; 1965 May; 115():427-9. PubMed ID: 14304574
    [No Abstract]   [Full Text] [Related]  

  • 18. INTERMITTENT FUNGAL THERAPY.
    SNYDER WE
    Vet Med Small Anim Clin; 1965 Jul; 60():726-7. PubMed ID: 14301298
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of griseofulvin on experimental infections. II.
    MARTIN AR
    Trans St Johns Hosp Dermatol Soc; 1960; 45():12-3. PubMed ID: 13767311
    [No Abstract]   [Full Text] [Related]  

  • 20. Griseofulvin: therapeutic results in different dermatomycosis after 22 weeks of treatment: effect on experimental dermatomycosis in man.
    ESTEVES J; NEVES H
    Dermatologica; 1959 Sep; 119():148-58. PubMed ID: 13848298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.